ML-141
new
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 530539

CAS#: 71203-35-5

Description: ML-141, also known as CID2950007, is a Cdc42 inhibitor (EC50 = 2.1 µM).


Chemical Structure

img
ML-141
CAS# 71203-35-5

Theoretical Analysis

MedKoo Cat#: 530539
Name: ML-141
CAS#: 71203-35-5
Chemical Formula: C22H21N3O3S
Exact Mass: 407.13
Molecular Weight: 407.488
Elemental Analysis: C, 64.85; H, 5.19; N, 10.31; O, 11.78; S, 7.87

Price and Availability

Size Price Availability Quantity
100mg USD 450
200mg USD 750
500mg USD 1450
1g USD 2450
2g USD 3850
5g USD 5750
Bulk inquiry

Synonym: ML-141; ML 141; ML141; CID2950007; CID-2950007; CID 2950007.

IUPAC/Chemical Name: 4-[4,5-dihydro-5-(4-methoxyphenyl)-3-phenyl-1H-pyrazol-1-yl]-benzenesulfonamide

InChi Key: QBNZBMVRFYREHK-UHFFFAOYSA-N

InChi Code: InChI=1S/C22H21N3O3S/c1-28-19-11-7-17(8-12-19)22-15-21(16-5-3-2-4-6-16)24-25(22)18-9-13-20(14-10-18)29(23,26)27/h2-14,22H,15H2,1H3,(H2,23,26,27)

SMILES Code: O=S(C1=CC=C(N2N=C(C3=CC=CC=C3)CC2C4=CC=C(OC)C=C4)C=C1)(N)=O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Product Data:
Biological target: ML141 (CID-2950007) is a potent, allosteric, selective and reversible non-competitive inhibitor of Cdc42 GTPase.
In vitro activity: This study reports here the characterization of a Cdc42-selective guanine nucleotide binding lead inhibitor (CID-2950007) that was identified by high throughput screening. Biochemical characterization showed that the compounds act as noncompetitive allosteric inhibitors. When tested in cellular assays, the lead compound inhibited Cdc42-related filopodia formation and cell migration. The lead compound was also used to clarify the involvement of Cdc42 in the Sin Nombre virus internalization and the signaling pathway of integrin VLA-4. Reference: J Biol Chem. 2013 Mar 22;288(12):8531-8543. https://pubmed.ncbi.nlm.nih.gov/23382385/
In vivo activity: After 24 h, ML141-injected mice spent less time than saline-injected controls in the anxiogenic center of an open field, preferring its periphery (Fig. 6C and D, n = 7, Student's t-test: P < 0.01 in all cases). Parallel suppression of the conserved brain CDC42 activity by intracerebroventricular ML141 injection caused acute anxiety in mice. Reference: Hum Mol Genet. 2014 Sep 1;23(17):4569-80. https://pubmed.ncbi.nlm.nih.gov/24722204/

Solubility Data

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
DMF 30.0 73.62
DMF:PBS (pH 7.2) (1:4) 0.2 0.49
DMSO 38.6 94.69

Preparing Stock Solutions

The following data is based on the product molecular weight 407.49 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol: 1. Chen HY, Yang YM, Stevens BM, Noble M. Inhibition of redox/Fyn/c-Cbl pathway function by Cdc42 controls tumour initiation capacity and tamoxifen sensitivity in basal-like breast cancer cells. EMBO Mol Med. 2013 May;5(5):723-36. doi: 10.1002/emmm.201202140. Epub 2013 Apr 22. PMID: 23606532; PMCID: PMC3662315. 2. Hong L, Kenney SR, Phillips GK, Simpson D, Schroeder CE, Nöth J, Romero E, Swanson S, Waller A, Strouse JJ, Carter M, Chigaev A, Ursu O, Oprea T, Hjelle B, Golden JE, Aubé J, Hudson LG, Buranda T, Sklar LA, Wandinger-Ness A. Characterization of a Cdc42 protein inhibitor and its use as a molecular probe. J Biol Chem. 2013 Mar 22;288(12):8531-8543. doi: 10.1074/jbc.M112.435941. Epub 2013 Feb 4. Erratum in: J Biol Chem. 2014 Mar 7;289(10):6837. PMID: 23382385; PMCID: PMC3605667. 3. Du H, Zhou H, Sun Y, Zhai X, Chen Z, Wang Y, Xu Z. The Rho GTPase Cell Division Cycle 42 Regulates Stereocilia Development in Cochlear Hair Cells. Front Cell Dev Biol. 2021 Oct 22;9:765559. doi: 10.3389/fcell.2021.765559. PMID: 34746154; PMCID: PMC8570139. 4. Hanin G, Shenhar-Tsarfaty S, Yayon N, Yau YH, Bennett ER, Sklan EH, Rao DC, Rankinen T, Bouchard C, Geifman-Shochat S, Shifman S, Greenberg DS, Soreq H. Competing targets of microRNA-608 affect anxiety and hypertension. Hum Mol Genet. 2014 Sep 1;23(17):4569-80. doi: 10.1093/hmg/ddu170. Epub 2014 Apr 9. Erratum in: Hum Mol Genet. 2014 Dec 15;23(24):6694. Hoe, Yau Yin [corrected to Yau, Yin Hoe]. PMID: 24722204; PMCID: PMC4119407.
In vitro protocol: 1. Chen HY, Yang YM, Stevens BM, Noble M. Inhibition of redox/Fyn/c-Cbl pathway function by Cdc42 controls tumour initiation capacity and tamoxifen sensitivity in basal-like breast cancer cells. EMBO Mol Med. 2013 May;5(5):723-36. doi: 10.1002/emmm.201202140. Epub 2013 Apr 22. PMID: 23606532; PMCID: PMC3662315. 2. Hong L, Kenney SR, Phillips GK, Simpson D, Schroeder CE, Nöth J, Romero E, Swanson S, Waller A, Strouse JJ, Carter M, Chigaev A, Ursu O, Oprea T, Hjelle B, Golden JE, Aubé J, Hudson LG, Buranda T, Sklar LA, Wandinger-Ness A. Characterization of a Cdc42 protein inhibitor and its use as a molecular probe. J Biol Chem. 2013 Mar 22;288(12):8531-8543. doi: 10.1074/jbc.M112.435941. Epub 2013 Feb 4. Erratum in: J Biol Chem. 2014 Mar 7;289(10):6837. PMID: 23382385; PMCID: PMC3605667.
In vivo protocol: 1. Du H, Zhou H, Sun Y, Zhai X, Chen Z, Wang Y, Xu Z. The Rho GTPase Cell Division Cycle 42 Regulates Stereocilia Development in Cochlear Hair Cells. Front Cell Dev Biol. 2021 Oct 22;9:765559. doi: 10.3389/fcell.2021.765559. PMID: 34746154; PMCID: PMC8570139. 2. Hanin G, Shenhar-Tsarfaty S, Yayon N, Yau YH, Bennett ER, Sklan EH, Rao DC, Rankinen T, Bouchard C, Geifman-Shochat S, Shifman S, Greenberg DS, Soreq H. Competing targets of microRNA-608 affect anxiety and hypertension. Hum Mol Genet. 2014 Sep 1;23(17):4569-80. doi: 10.1093/hmg/ddu170. Epub 2014 Apr 9. Erratum in: Hum Mol Genet. 2014 Dec 15;23(24):6694. Hoe, Yau Yin [corrected to Yau, Yin Hoe]. PMID: 24722204; PMCID: PMC4119407.

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Shen J, Wang R, He Z, Huang H, He X, Zhou J, Yan Y, Shen S, Shao X, Shen X, Weng C, Lin W, Chen J. NMDA receptors participate in the progression of diabetic kidney disease by decreasing Cdc42-GTP activation in podocytes. J Pathol. 2016 Oct;240(2):149-60. doi: 10.1002/path.4764. PubMed PMID: 27338016.

2: Zhan Y, Liang X, Li L, Wang B, Ding F, Li Y, Wang X, Zhan Q, Liu Z. MicroRNA-548j functions as a metastasis promoter in human breast cancer by targeting Tensin1. Mol Oncol. 2016 Jun;10(6):838-49. doi: 10.1016/j.molonc.2016.02.002. PubMed PMID: 26949125.

3: Oprea TI, Sklar LA, Agola JO, Guo Y, Silberberg M, Roxby J, Vestling A, Romero E, Surviladze Z, Murray-Krezan C, Waller A, Ursu O, Hudson LG, Wandinger-Ness A. Novel Activities of Select NSAID R-Enantiomers against Rac1 and Cdc42 GTPases. PLoS One. 2015 Nov 11;10(11):e0142182. doi: 10.1371/journal.pone.0142182. PubMed PMID: 26558612; PubMed Central PMCID: PMC4641600.

4: Guo Y, Kenney SR, Muller CY, Adams S, Rutledge T, Romero E, Murray-Krezan C, Prekeris R, Sklar LA, Hudson LG, Wandinger-Ness A. R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis. Mol Cancer Ther. 2015 Oct;14(10):2215-27. doi: 10.1158/1535-7163.MCT-15-0419. PubMed PMID: 26206334; PubMed Central PMCID: PMC4596774.

5: Cheng SL, Ramachandran B, Behrmann A, Shao JS, Mead M, Smith C, Krchma K, Bello Arredondo Y, Kovacs A, Kapoor K, Brill LM, Perera R, Williams BO, Towler DA. Vascular smooth muscle LRP6 limits arteriosclerotic calcification in diabetic LDLR-/- mice by restraining noncanonical Wnt signals. Circ Res. 2015 Jul 3;117(2):142-56. doi: 10.1161/CIRCRESAHA.117.306712. PubMed PMID: 26034040; PubMed Central PMCID: PMC4490945.

6: Ferru-Clément R, Fresquet F, Norez C, Métayé T, Becq F, Kitzis A, Thoreau V. Involvement of the Cdc42 pathway in CFTR post-translational turnover and in its plasma membrane stability in airway epithelial cells. PLoS One. 2015 Mar 13;10(3):e0118943. doi: 10.1371/journal.pone.0118943. PubMed PMID: 25768293; PubMed Central PMCID: PMC4359135.

7: Zhang Y, Liu J, Luan G, Wang X. Inhibition of the small GTPase Cdc42 in regulation of epileptic-seizure in rats. Neuroscience. 2015 Mar 19;289:381-91. doi: 10.1016/j.neuroscience.2014.12.059. PubMed PMID: 25595978.

8: Hsu CR, Pan YJ, Liu JY, Chen CT, Lin TL, Wang JT. Klebsiella pneumoniae translocates across the intestinal epithelium via Rho GTPase- and phosphatidylinositol 3-kinase/Akt-dependent cell invasion. Infect Immun. 2015 Feb;83(2):769-79. doi: 10.1128/IAI.02345-14. PubMed PMID: 25452552; PubMed Central PMCID: PMC4294243.

9: Kumar A, Al-Sammarraie N, DiPette DJ, Singh US. Metformin impairs Rho GTPase signaling to induce apoptosis in neuroblastoma cells and inhibits growth of tumors in the xenograft mouse model of neuroblastoma. Oncotarget. 2014 Nov 30;5(22):11709-22. PubMed PMID: 25365944; PubMed Central PMCID: PMC4294363.

10: Antolín AA, Mestres J. Distant polypharmacology among MLP chemical probes. ACS Chem Biol. 2015 Feb 20;10(2):395-400. doi: 10.1021/cb500393m. PubMed PMID: 25365788.

11: Chen C, Song X, Ma S, Wang X, Xu J, Zhang H, Wu Q, Zhao K, Cao J, Qiao J, Sun X, Li D, Zeng L, Li Z, Xu K. Cdc42 inhibitor ML141 enhances G-CSF-induced hematopoietic stem and progenitor cell mobilization. Int J Hematol. 2015 Jan;101(1):5-12. doi: 10.1007/s12185-014-1690-z. PubMed PMID: 25315193.

12: Weinberg MS, Nicolson S, Bhatt AP, McLendon M, Li C, Samulski RJ. Recombinant adeno-associated virus utilizes cell-specific infectious entry mechanisms. J Virol. 2014 Nov;88(21):12472-84. doi: 10.1128/JVI.01971-14. PubMed PMID: 25142580; PubMed Central PMCID: PMC4248914.

13: Hanin G, Shenhar-Tsarfaty S, Yayon N, Yau YH, Bennett ER, Sklan EH, Rao DC, Rankinen T, Bouchard C, Geifman-Shochat S, Shifman S, Greenberg DS, Soreq H. Competing targets of microRNA-608 affect anxiety and hypertension. Hum Mol Genet. 2014 Sep 1;23(17):4569-80. doi: 10.1093/hmg/ddu170. Erratum in: Hum Mol Genet. 2014 Dec 15;23(24):6694. Hoe, Yau Yin [corrected to Yau, Yin Hoe]. PubMed PMID: 24722204; PubMed Central PMCID: PMC4119407.

14: McNary SM, Athanasiou KA, Reddi AH. Transforming growth factor β-induced superficial zone protein accumulation in the surface zone of articular cartilage is dependent on the cytoskeleton. Tissue Eng Part A. 2014 Mar;20(5-6):921-9. doi: 10.1089/ten.TEA.2013.0043. PubMed PMID: 24116978; PubMed Central PMCID: PMC3938930.

15: Chen HY, Yang YM, Stevens BM, Noble M. Inhibition of redox/Fyn/c-Cbl pathway function by Cdc42 controls tumour initiation capacity and tamoxifen sensitivity in basal-like breast cancer cells. EMBO Mol Med. 2013 May;5(5):723-36. doi: 10.1002/emmm.201202140. PubMed PMID: 23606532; PubMed Central PMCID: PMC3662315.

16: Surviladze Z, Waller A, Strouse JJ, Bologa C, Ursu O, Salas V, Parkinson JF, Phillips GK, Romero E, Wandinger-Ness A, Sklar LA, Schroeder C, Simpson D, Nöth J, Wang J, Golden J, Aubé J. A Potent and Selective Inhibitor of Cdc42 GTPase. 2010 Feb 27 [updated 2010 Dec 16]. Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-. Available from http://www.ncbi.nlm.nih.gov/books/NBK51965/ PubMed PMID: 21433396.